Cargando…
Vibrio Phage VMJ710 Can Prevent and Treat Disease Caused by Pathogenic MDR V. cholerae O1 in an Infant Mouse Model
Cholera, a disease of antiquity, is still festering in developing countries that lack safe drinking water and sewage disposal. Vibrio cholerae, the causative agent of cholera, has developed multi-drug resistance to many antimicrobial agents. In aquatic habitats, phages are known to influence the occ...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295236/ https://www.ncbi.nlm.nih.gov/pubmed/37370365 http://dx.doi.org/10.3390/antibiotics12061046 |
_version_ | 1785063372394332160 |
---|---|
author | Chaudhary, Naveen Mohan, Balvinder Kaur, Harpreet Modgil, Vinay Kant, Vishal Bhatia, Alka Taneja, Neelam |
author_facet | Chaudhary, Naveen Mohan, Balvinder Kaur, Harpreet Modgil, Vinay Kant, Vishal Bhatia, Alka Taneja, Neelam |
author_sort | Chaudhary, Naveen |
collection | PubMed |
description | Cholera, a disease of antiquity, is still festering in developing countries that lack safe drinking water and sewage disposal. Vibrio cholerae, the causative agent of cholera, has developed multi-drug resistance to many antimicrobial agents. In aquatic habitats, phages are known to influence the occurrence and dispersion of pathogenic V. cholerae. We isolated Vibrio phage VMJ710 from a community sewage water sample of Manimajra, Chandigarh, in 2015 during an outbreak of cholera. It lysed 46% of multidrug-resistant V. cholerae O1 strains. It had significantly reduced the bacterial density within the first 4–6 h of treatment at the three multiplicity of infection (MOI 0.01, 0.1, and 1.0) values used. No bacterial resistance was observed against phage VMJ710 for 20 h in the time–kill assay. It is nearest to an ICP1 phage, i.e., Vibrio phage ICP1_2012 (MH310936.1), belonging to the class Caudoviricetes. ICP1 phages have been the dominant bacteriophages found in cholera patients’ stools since 2001. Comparative genome analysis of phage VMJ710 and related phages indicated a high level of genetic conservation. The phage was stable over a wide range of temperatures and pH, which will be an advantage for applications in different environmental settings. The phage VMJ710 showed a reduction in biofilm mass growth, bacterial dispersal, and a clear disruption of bacterial biofilm structure. We further tested the phage VMJ710 for its potential therapeutic and prophylactic properties using infant BALB/c mice. Bacterial counts were reduced significantly when phages were administered before and after the challenge of orogastric inoculation with V. cholerae serotype O1. A comprehensive whole genome study revealed no indication of lysogenic genes, genes associated with possible virulence factors, or antibiotic resistance. Based on all these properties, phage VMJ710 can be a suitable candidate for oral phage administration and could be a viable method of combatting cholera infection caused by MDR V. cholerae pathogenic strains. |
format | Online Article Text |
id | pubmed-10295236 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-102952362023-06-28 Vibrio Phage VMJ710 Can Prevent and Treat Disease Caused by Pathogenic MDR V. cholerae O1 in an Infant Mouse Model Chaudhary, Naveen Mohan, Balvinder Kaur, Harpreet Modgil, Vinay Kant, Vishal Bhatia, Alka Taneja, Neelam Antibiotics (Basel) Article Cholera, a disease of antiquity, is still festering in developing countries that lack safe drinking water and sewage disposal. Vibrio cholerae, the causative agent of cholera, has developed multi-drug resistance to many antimicrobial agents. In aquatic habitats, phages are known to influence the occurrence and dispersion of pathogenic V. cholerae. We isolated Vibrio phage VMJ710 from a community sewage water sample of Manimajra, Chandigarh, in 2015 during an outbreak of cholera. It lysed 46% of multidrug-resistant V. cholerae O1 strains. It had significantly reduced the bacterial density within the first 4–6 h of treatment at the three multiplicity of infection (MOI 0.01, 0.1, and 1.0) values used. No bacterial resistance was observed against phage VMJ710 for 20 h in the time–kill assay. It is nearest to an ICP1 phage, i.e., Vibrio phage ICP1_2012 (MH310936.1), belonging to the class Caudoviricetes. ICP1 phages have been the dominant bacteriophages found in cholera patients’ stools since 2001. Comparative genome analysis of phage VMJ710 and related phages indicated a high level of genetic conservation. The phage was stable over a wide range of temperatures and pH, which will be an advantage for applications in different environmental settings. The phage VMJ710 showed a reduction in biofilm mass growth, bacterial dispersal, and a clear disruption of bacterial biofilm structure. We further tested the phage VMJ710 for its potential therapeutic and prophylactic properties using infant BALB/c mice. Bacterial counts were reduced significantly when phages were administered before and after the challenge of orogastric inoculation with V. cholerae serotype O1. A comprehensive whole genome study revealed no indication of lysogenic genes, genes associated with possible virulence factors, or antibiotic resistance. Based on all these properties, phage VMJ710 can be a suitable candidate for oral phage administration and could be a viable method of combatting cholera infection caused by MDR V. cholerae pathogenic strains. MDPI 2023-06-14 /pmc/articles/PMC10295236/ /pubmed/37370365 http://dx.doi.org/10.3390/antibiotics12061046 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Chaudhary, Naveen Mohan, Balvinder Kaur, Harpreet Modgil, Vinay Kant, Vishal Bhatia, Alka Taneja, Neelam Vibrio Phage VMJ710 Can Prevent and Treat Disease Caused by Pathogenic MDR V. cholerae O1 in an Infant Mouse Model |
title | Vibrio Phage VMJ710 Can Prevent and Treat Disease Caused by Pathogenic MDR V. cholerae O1 in an Infant Mouse Model |
title_full | Vibrio Phage VMJ710 Can Prevent and Treat Disease Caused by Pathogenic MDR V. cholerae O1 in an Infant Mouse Model |
title_fullStr | Vibrio Phage VMJ710 Can Prevent and Treat Disease Caused by Pathogenic MDR V. cholerae O1 in an Infant Mouse Model |
title_full_unstemmed | Vibrio Phage VMJ710 Can Prevent and Treat Disease Caused by Pathogenic MDR V. cholerae O1 in an Infant Mouse Model |
title_short | Vibrio Phage VMJ710 Can Prevent and Treat Disease Caused by Pathogenic MDR V. cholerae O1 in an Infant Mouse Model |
title_sort | vibrio phage vmj710 can prevent and treat disease caused by pathogenic mdr v. cholerae o1 in an infant mouse model |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295236/ https://www.ncbi.nlm.nih.gov/pubmed/37370365 http://dx.doi.org/10.3390/antibiotics12061046 |
work_keys_str_mv | AT chaudharynaveen vibriophagevmj710canpreventandtreatdiseasecausedbypathogenicmdrvcholeraeo1inaninfantmousemodel AT mohanbalvinder vibriophagevmj710canpreventandtreatdiseasecausedbypathogenicmdrvcholeraeo1inaninfantmousemodel AT kaurharpreet vibriophagevmj710canpreventandtreatdiseasecausedbypathogenicmdrvcholeraeo1inaninfantmousemodel AT modgilvinay vibriophagevmj710canpreventandtreatdiseasecausedbypathogenicmdrvcholeraeo1inaninfantmousemodel AT kantvishal vibriophagevmj710canpreventandtreatdiseasecausedbypathogenicmdrvcholeraeo1inaninfantmousemodel AT bhatiaalka vibriophagevmj710canpreventandtreatdiseasecausedbypathogenicmdrvcholeraeo1inaninfantmousemodel AT tanejaneelam vibriophagevmj710canpreventandtreatdiseasecausedbypathogenicmdrvcholeraeo1inaninfantmousemodel |